antivirals
Showing 1 - 25 of 384
Real World COVID-19 Antiviral Effectiveness Research
Not yet recruiting
- COVID-19
- Oral Antiviral
- (no location specified)
Dec 4, 2022
Cytomegalovirus Anterior Uveitis Trial in San Francisco (Valganciclovir Hydrochloride, Ganciclovir Sodium, Placebo Oral Tablet)
Recruiting
- Cytomegalovirus Anterior Uveitis
- Valganciclovir Hydrochloride
- +3 more
-
San Francisco, CaliforniaProctor Foundation, UCSF
Jul 1, 2022
HCV Trial in United States (Prophylaxis (P2W), Transmit and Treat (T&T))
Not yet recruiting
- HCV
- Prophylaxis (P2W)
- Transmit and Treat (T&T)
-
New Orleans, Louisiana
- +5 more
Dec 6, 2022
Validation of Drug Assays in Various Biological Matrices
Recruiting
- Infection
- antivirals, antimicrobials, oral contraceptive, erectile dysfunction agents
-
Liverpool, United KingdomRoyal Liverpool & Broadgreen Univeristy Hospitals NHS Trust
Nov 1, 2022
Hepatocellular Carcinoma, Hepatitis C, Tumor Recurrence Trial in Alexandria (Velpatasvir/Sofosbuvir)
Active, not recruiting
- Hepatocellular Carcinoma
- +3 more
-
Alexandria, EgyptAlexandria University, Faculty of Medicine
Jan 14, 2022
Long Term Follow up of Chronic HCV Patients Receiving DAAS
Recruiting
- Chronic Hepatitis c
-
Sohag, EgyptSohag University Hospital
Jun 29, 2022
The Treatment in Pregnancy for Hepatitis C ("TiP-HepC") Registry
Recruiting
- Hepatitis C
- Direct Acting Antivirals
-
Atlanta, GeorgiaThe Taskforce for Global Health
May 6, 2022
Chronic Hepatitis c After Treatment With Direct Action
Completed
- Hepatitis C, Chronic
-
Sevilla, SpainHospital Universitario Virgen macarena
Nov 15, 2021
Treatment of Hepatitis c by Using Direct-acting Antiviral
Not yet recruiting
- Hepatitis C
- Direct Acting Antivirals
- (no location specified)
May 9, 2022
Long Term Follow-up of Hepatitis C Cured Patients
Completed
- Chronic Hepatitis C
- +2 more
- (no location specified)
Sep 19, 2022
Herpes Simplex Virus Keratitis Trial in New York (oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily, oral acyclovir 400 mg
Withdrawn
- Herpes Simplex Virus Keratitis
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily
- oral acyclovir 400 mg BID OR valacyclovir 500 mg qdaily + topical corticosteroid eye drops
-
New York, New YorkNew York University School of Medicine
Dec 29, 2021
Possible Differences in HCC Course Depending on DAA Treatment
Recruiting
- Carcinoma, Hepatocellular
- +5 more
- Direct Acting Antivirals
-
Warsaw, Mazowieckie, PolandMedical University of Warsaw
May 11, 2022
Against HCV Based on Direct-acting Antivirals in Real-life
Completed
- Chronic Hepatitis C Infection
- Telaprevir
- +10 more
-
Seville, Andalusia, SpainValme University Hospital
Jun 22, 2022
Volunteer Screening for Vaccine and Antivirals Clinical Trials
Completed
- Normal Physiology
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 30, 2021
DAA Uptake in Controlling HCV Epidemic and Modeling
Recruiting
- Hepatitis C
- +2 more
-
San Diego, CaliforniaOwen Clinic-University of California, San Diego
Sep 1, 2021
Covid19 Trial in Ciudad de Mexico (Favipiravir, Nitazoxanide, Nitazoxanide Placebo)
Recruiting
- Covid19
- Favipiravir
- +2 more
-
Ciudad de Mexico, Azcapotzalco, MexicoHospital de Infectología "Daniel Méndez Hernández" del Centro Mé
Oct 18, 2021
Chronic Hepatitis B Trial in Auckland (TAF, TDF, Other approved antivirals)
Different Antiviral Regimens for Hepatitis C Virus Relapse
Unknown status
- Hepatitis C
- +2 more
- directly acting antivirals
-
Alexandria, EgyptAlexandria University.
Dec 4, 2020